Metraipolis › archive › dc_fc4e1881d974
K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation — Europe PMC PMID:40550849
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40550849
- DOI
- 10.1038/s41598-[numero omesso]-5
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T13:43:53.199Z
- SHA-256 of the archived text
b7d69bc1d45900a8b92b529ab603248b3cbdc0819953f05e24a9b088d4f3840c- Stable URL of this page
https://metraipolis.com/documento/dc_fc4e1881d974
How to cite
K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation — Europe PMC PMID:40550849 — Europe PMC (en), https://europepmc.org/article/MED/40550849 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc4e1881d974 (Metraipolis archive dc_fc4e1881d974, sha256 b7d69bc1d45900a8b92b529ab603248b3cbdc0819953f05e24a9b088d4f3840c)
BibTeX
@misc{dcfc4e1881d974,
title = {K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation — Europe PMC PMID:40550849},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40550849},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc4e1881d974; sha256 b7d69bc1d45900a8b92b529ab603248b3cbdc0819953f05e24a9b088d4f3840c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40550849. Agents can read the archived copy with the MCP tool read_document.